Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry

Therapy and Intervention

Comparison of Benefit of Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients With Versus Without Reduced (≤40%) Left Ventricular Ejection Fraction

Am J Cardiol.

Toma A, Stähli BE, Gick M, Gebhard C, Kaufmann BA, Mashayekhi K, Ferenc M, Buettner HJ, Neumann FJ

doi: 10.1016/j.amjcard.

Therapy and Intervention

Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry

JACC Cardiovasc Interv.

Tajti P, Alaswad K, Karmpaliotis D, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky BF, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Khatri JJ, Jaber W, Samady H, Jefferson B, Patel T, Abdullah S, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES

doi: 10.1016/j.jcin.2018.11.019.

Therapy and Intervention

Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status

J Am Heart Assoc.

Peri-Okonny PA, Spertus JA, Grantham JA, Gosch K, Kirtane A, Sapontis J, Lombardi W, Karmpaliotis D, Moses J, Nicholson W, Salisbury AC

doi: 10.1161/JAHA.

Therapy and Intervention

Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry: The EuroCTO (CASTLE) Score

JACC Cardiovasc Interv.

Szijgyarto Z, Rampat R, Werner GS, Ho C, Reifart N, Lefevre T, Louvard Y, Avran A, Kambis M, Buettner HJ, Di Mario C, Gershlick A, Escaned J, Sianos G, Galassi A, Garbo R, Goktekin O, Meyer-Gessner M, Lauer B, Elhadad S, Bufe A, Boudou N, Sievert H, Martin-Yuste V, Thuesen L, Erglis A, Christiansen E, Spratt J, Bryniarski L, Clayton T, Hildick-Smith D

doi: 10.1016/j.jcin.2018.11.020.

Myocardial InfarctionTherapy and Intervention

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions

Eur Heart J.

Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, Rumoroso JR, Erglis A, Christiansen EH, Escaned J, di Mario C, Hovasse T, Teruel L, Bufe A, Lauer B, Bogaerts K, Goicolea J, Spratt JC, Gershlick AH, Galassi AR, Louvard Y; EUROCTO trial investigators

doi: 10.1093/eurheartj/ehy220.

Heart, Artery and Coronary DiseasesHeart FailureMyocardial InfarctionTherapy and Intervention

Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block

J Am Coll Cardiol.

Sze E, Samad Z, Dunning A, Campbell KB, Loring Z, Atwater BD, Chiswell K, Kisslo JA, Velazquez EJ, Daubert JP

doi: 10.1016/j.jacc.2017.11.020.

COMMENTED

Heart, Artery and Coronary Diseases

Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction

★ 0 Recommended and commented by Prof. Dr Sacha P. Salzberg, Faculty Member

J Am Coll Cardiol

Park S, Ahn JM, Kim TO, Park H, Kang DY, Lee PH, Jeong YJ, Hyun J, Lee J, Kim JH, Yang Y, Choe K, Park SJ, Park DW, IRIS-MAIN Registry Investigators.

doi: 10.1016/j.jacc.2020.07.047

RECOMMENDED

Heart Failure

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Reduced Trial

★ 3 Recommended by Prof. Dr Isabella Sudano, Faculty Member

Circulation

Zannad F, Ferreira JP, Pocock SJ, Zeller C, Anker SD, Butler J, Filippatos G, Hauske SJ, Brueckmann M, Pfarr E, Schnee J, Wanner C, Packer M

doi: 10.1161/CIRCULATIONAHA.120.051685

Hypertension

Efficacy and Safety of Percutaneous Pulmonary Artery Subtotal Occlusion and Chronic Total Occlusion Intervention in Chronic Thromboembolic Pulmonary Hypertension

Circ Cardiovasc Interv

Gerges C, Friewald R, Gerges M, Shafran I, Sadushi-Koliçi R, Skoro-Sajer N, Moser B, Taghavi S, Klepetko W, Lang IM

doi: 10.1161/CIRCINTERVENTIONS.120.010243

Related content

Comparison of Benefit of Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients With Versus Without Reduced (≤40%) Left Ventricular Ejection Fraction

Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion Registry

Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status

Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry: The EuroCTO (CASTLE) Score

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions

Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block

Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Reduced Trial

Efficacy and Safety of Percutaneous Pulmonary Artery Subtotal Occlusion and Chronic Total Occlusion Intervention in Chronic Thromboembolic Pulmonary Hypertension